|Year|Brand|Company|Date|ProductDescription|Reason|Url|
|2018|Aurobindo|Aurobindo Pharma USA, Inc.|12/31/18|Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP, Valsartan Tablets USP|Undeclared N-nitrosodiethylamine (NDEA)|https://www.fda.gov/Safety/Recalls/ucm629213.htm|
|2018|Lubrisine|Results RNA LLC|12/31/18|Eye Drops|Undeclared colloidal silver and lack of sterility assurance|https://www.fda.gov/Safety/Recalls/ucm629256.htm|